Original Article
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Mehtap Aydın and others
Surgical site infections (SSI) are defined as infections that occur up to 30 days or one year after surgery in patients with implants, affecting the incision or deep tissue at the surgery site. They account for 20% of all healthcare-associated infections (HAI) in hospitalized patients. Patients with SSI are hospitalised additionally 7-11 days postoperatively. Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Ezgi Oralkan and others
The increase of colistin resistance in Acinetobacter baumannii is a great concern in various regions of the world such as Asia, Europe, and North and South America. Exposure to colistin is considered the most significant factor for emerging of colistin resistance; however, details of the in vivo response Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
İlker Kayı and others
Cervical cancer is the fourth leading cause of all cancers among women globally, and 90% of all deaths occur in low- and middle-income countries. Sexual intercourse is the main route of transmission for HPV infection. The course of HPV infection differs according to the HPV type, immune status of the women, Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Duygu Özkaya and others
Healthcare-associated infections (HAIs) are infections, which are not present at admission or might be in incubating, are acquired in the hospital. HAIs remain a major problem for they increase not only morbidity and mortality but also costs for health care systems. Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Altan Gökgöz and others
Infectious Diseases and Clinical Microbiology (IDCM) physicians have pivotal role in responding to the coronavirus disease 2019 (COVID-19) pandemic. Their involvement ranges from managing cases and coordinating local responses to establishing timely and accurate diagnostic testing. Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
İbrahim Etem Dural and Yasemin Nadir
The first case of COVID-19 was reported on 10 March 2020 in Turkey. Various treatment options have been used in all countries because of the lack of proven treatment. Among these options, hydroxychloroquine (HQN) and azithromycin (AZ) combination is expected to treat Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Bahar Madran and others
A new coronavirus (SARS-CoV-2) appeared at the end of 2019 in China and spread widely throughout the world. The coronavirus disease 2019 (COVID-19) is a new respiratory disease, and its pandemic has affected more than seven million people all around the world. The first COVID-19 case in Turkey was detected on Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Zeynep Türe and others
In December 2019, Wuhan city, the capital of Hubei province in China, became the center of an outbreak of pneumonia of unknown cause. By Jan 7, 2020, Chinese scientists had isolated a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV), from these Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Vildan Avkan-Oğuz and others
Complicated intra-abdominal infection (cIAI) is defined as localized or diffuse peritonitis with the involvement of multiple intraperitoneal organs. Source control and appropriate empirical antibiotics are essentials of the treatment. There are few clinical and microbiologic studies regarding cIAI in Turkey. Empiric antibiotics were selected due to diagnoses; community-acquired IAI (CA-IAI) or healthcare-associated IAI. Guidelines published on this topic lack definitive criteria for CA-IAI. Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Özgür Can Eren and others
In 2019, more than 36 million people were estimated to be harboring HIV, and the epidemic caused 39 million deaths worldwide to date. New adult infections have been declined by 17% between 2007 and 2017 globally. Meanwhile, the incidence has an Read More
Original Article
/ VOLUME 2, ISSUE 1, APRIL 2020
Çiğdem Akalan Kuyumcu and others
Brucellosis is a zoonotic infectious disease caused by Gram-negative bacteria of the genus Brucella, which is transmitted from animals to humans by direct and indirect pathways. Brucellosis can be confused with various infectious and non-infectious diseases because of its nonspecific clinical signs and symptoms such as fever, sweating, Read More
Original Article
/ VOLUME 2, ISSUE 1, APRIL 2020
Ahmet Özbilgin and others
Visceral Leishmaniasis (VL) is a widespread infectious disease of the reticuloendothelial system which is mostly caused by Leishmania infantum (L. infantum) and L. donovani in the Old World. The disease is endemic in many parts of the world, and estimated cases of VL have reached 300,000 globally with a high rate of HIV co-infection, and over Read More
Original Article
/ VOLUME 2, ISSUE 1, APRIL 2020
İrem Akdemir Kalkan and others
Influenza is a systemic infectious disease. Many groups, including patients with concomitant chronic heart and lung diseases, immunosuppressed individuals, people over 50 years old, and all health staff are considered at-risk groups for influenza. Pregnant women are particularly considered to be at a higher risk. Read More
Original Article
/ VOLUME 1, ISSUE 3, DECEMBER 2019
Anna Pierro and others
Hepatitis E virus (HEV) represents one of the major cause of acute viral hepatitis worldwide, according to the WHO, one-third of the world population has been exposed to HEV. In Europe, there is extensive evidence indicating that HEV is prevalently transmitted by the ingestion of pork and wild boar raw meat, however, [...] Read More
Original Article
/ VOLUME 1, ISSUE 3, DECEMBER 2019
Aycan Gündoğdu and others
Infectious diseases are the leading causes of mortality and morbidity worldwide. Current diagnosis of clinically significant infectious agents is based on a variety of laboratory-based tests including microscopy, culture, immunoassays and nucleic acid amplification. The majority of these techniques relies on conventional culture-based profiling […] Read More
Original Article
/ VOLUME 1, ISSUE 3, DECEMBER 2019
Alpay Azap and others
The discovery of antibiotics has been a milestone for the treatment of infectious diseases. However, soon after antimicrobials came into use, it has been recognized that microorganisms become resistant. Antimicrobial resistance decreases the number of treatment options available in infectious diseases. Currently, antimicrobial resistance has become an issue […] Read More
Original Article
/ VOLUME 1, ISSUE 2, AUGUST 2019
Mehtap Aydın and others
Antibiotics are the most widely prescribed drugs in dentistry. Irrational use of antibiotics (IUA) is common in Turkey and other countries. However, IUA leads to the development of antibiotic resistance, which can significantly affect the quality health care and increase the cost. Emerging [...] Read More
Original Article
/ VOLUME 1, ISSUE 2, AUGUST 2019
Selda Sayın Kutlu and others
Visceral leishmaniasis (VL) is one of the important life-threatening infectious diseases worldwide. The highest prevalence of VL is in Brazil, East Africa and in South-East Asia, with an estimate of 50,000 to 90,000 new cases each year. VL is an anthroponotic and zoonotic disease. While [...] Read More
Original Article
/ VOLUME 1, ISSUE 2, AUGUST 2019
Sinem Ayaz and others
Even though Candida albicans is the most isolated fungus from clinical specimens, in recent years, there has been an increase in isolation of non-Candida spp.including Trichosporon asahii. T. asahii is an arthroconidial yeast belonging to the Trichosporonaceae family of the Basidiomycota phylum taxonomically. It can be found in nature as well as in [...] Read More
Original Article
/ VOLUME 1, ISSUE 2, AUGUST 2019
Ezgi Gülten and others
Seasonal influenza is an important cause of mortality, particularly in immunocompromised and elderly patients, children, pregnant and postpartum women. Iuliano et al. estimated that each year 291,243 to 645,832 deaths are attributed to seasonal influenza. Turkey is located in the northern hemisphere; therefore, the majority of the influenza cases occur between October and [...] Read More